Optimind Pharma Corp. (OMND.CN)
| Previous Close | 0.0050 |
| Open | 0.0000 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's Range | 0.0050 - 0.0050 |
| 52 Week Range | 0.0050 - 0.0250 |
| Volume | |
| Avg. Volume | 20,498 |
| Market Cap | 521,940 |
| Beta (5Y Monthly) | -0.95 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0100 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NewsfileOptimind Pharma Closes Second Tranche of Private Placement
Toronto, Ontario--(Newsfile Corp. - July 29, 2024) - Optimind Pharma Corp. (CSE: OMND) ("Optimind" or the "Company") announces it has closed the second trance of its previously announced private placement. The Company issued 2,500,000 common shares at a price of $0.05 per share to investors for gross proceeds of $125,000. The Company expects to close a third tranche of the private placement in the next couple of weeks.Net proceeds will be used for working capital. ...
NewsfileOptimind Pharma Closes First Tranche of Private Placement
Toronto, Ontario--(Newsfile Corp. - July 8, 2024) - Optimind Pharma Corp. (CSE: OMND) ("Optimind" or the "Company") announces it has closed the first trance of its previously announced private placement. The Company issued 2,900,000 common shares at a price of $0.05 per share to investors for gross proceeds of $145,000.The Company expects to close a second tranche of the private placement in the next couple of weeks.Net proceeds will be used for working capital. ...
NewsfileOptimind Pharma - Private Placement
Toronto, Ontario--(Newsfile Corp. - July 3, 2024) - Optimind Pharma Corp. (CSE: OMND) (the "Optimind" or the "Company") announces a proposed private placement. The Company intends to issue up to 10,000,000 common shares (the "Shares") at a price of $0.05 per share for gross proceeds of up to $500,000. Net proceeds will be used for working capital. All securities issued in connection with the private placement will be subject to a statutory hold period ...
